Pembrolizumab—the “KEY” to an evolving landscape in treatment of squamous non-small cell lung cancer (NSCLC)
@article{TLCR38119, author = {Amulya Yellala and Apar Kishor Ganti}, title = {Pembrolizumab—the “KEY” to an evolving landscape in treatment of squamous non-small cell lung cancer (NSCLC)}, journal = {Translational Lung Cancer Research}, volume = {9}, number = {3}, year = {2020}, keywords = {}, abstract = {}, issn = {2226-4477}, url = {https://tlcr.amegroups.org/article/view/38119} }